End-of-day quote
Shanghai S.E.
06:00:00 2024-05-14 pm EDT
|
5-day change
|
1st Jan Change
|
42.62
CNY
|
-1.21%
|
|
-4.57%
|
-7.06%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
7,098
|
10,217
|
40,129
|
18,707
|
8,547
|
-
|
-
|
Enterprise Value (EV)
1 |
7,098
|
10,217
|
40,129
|
18,707
|
8,547
|
8,547
|
8,547
|
P/E ratio
|
23
x
|
39.4
x
|
34.1
x
|
21
x
|
59.2
x
|
36.4
x
|
24.2
x
|
Yield
|
-
|
1.19%
|
0.15%
|
0.33%
|
0.09%
|
0.14%
|
0.21%
|
Capitalization / Revenue
|
-
|
2.28
x
|
5.69
x
|
2.25
x
|
1.43
x
|
1.37
x
|
1.31
x
|
EV / Revenue
|
-
|
2.28
x
|
5.69
x
|
2.25
x
|
1.43
x
|
1.37
x
|
1.31
x
|
EV / EBITDA
|
-
|
-
|
24,217,386
x
|
15,955,240
x
|
-
|
-
|
-
|
EV / FCF
|
-
|
-
|
64,196,262
x
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
0%
|
-
|
-
|
-
|
-
|
Price to Book
|
-
|
4.96
x
|
12.9
x
|
4.75
x
|
2.14
x
|
2.03
x
|
1.88
x
|
Nbr of stocks (in thousands)
|
202,680
|
202,680
|
202,680
|
202,680
|
202,680
|
-
|
-
|
Reference price
2 |
35.02
|
50.41
|
198.0
|
92.30
|
42.62
|
42.62
|
42.62
|
Announcement Date
|
4/9/20
|
3/29/21
|
4/8/22
|
4/24/23
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
-
|
4,475
|
7,056
|
8,316
|
5,962
|
6,256
|
6,538
|
EBITDA
|
-
|
-
|
1,657
|
1,172
|
-
|
-
|
-
|
EBIT
1 |
-
|
317.1
|
1,490
|
994.4
|
167
|
272
|
410
|
Operating Margin
|
-
|
7.09%
|
21.12%
|
11.96%
|
2.8%
|
4.35%
|
6.27%
|
Earnings before Tax (EBT)
1 |
-
|
314.6
|
1,502
|
1,024
|
169
|
274
|
412
|
Net income
1 |
308.5
|
259.8
|
1,178
|
890.5
|
146
|
237
|
356
|
Net margin
|
-
|
5.81%
|
16.7%
|
10.71%
|
2.45%
|
3.79%
|
5.45%
|
EPS
2 |
1.520
|
1.280
|
5.810
|
4.390
|
0.7200
|
1.170
|
1.760
|
Free Cash Flow
|
-
|
-
|
625.1
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
8.86%
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
37.72%
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
53.05%
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
0.6000
|
0.3000
|
0.3000
|
0.0400
|
0.0600
|
0.0900
|
Announcement Date
|
4/9/20
|
3/29/21
|
4/8/22
|
4/24/23
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
625
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
18.2%
|
13.4%
|
45.8%
|
25.3%
|
3.6%
|
5.6%
|
7.7%
|
ROA (Net income/ Total Assets)
|
-
|
7.97%
|
-
|
13.9%
|
1.9%
|
2.9%
|
4%
|
Assets
1 |
-
|
3,260
|
-
|
6,406
|
7,684
|
8,172
|
8,900
|
Book Value Per Share
2 |
-
|
10.20
|
15.30
|
19.40
|
19.90
|
21.00
|
22.70
|
Cash Flow per Share
2 |
-
|
3.910
|
4.730
|
4.180
|
2.620
|
2.880
|
3.680
|
Capex
1 |
-
|
185
|
335
|
680
|
789
|
813
|
801
|
Capex / Sales
|
-
|
4.13%
|
4.74%
|
8.18%
|
13.23%
|
13%
|
12.25%
|
Announcement Date
|
4/9/20
|
3/29/21
|
4/8/22
|
4/24/23
|
-
|
-
|
-
|
|
1st Jan change
|
Capi.
|
---|
| -7.06% | 1.2B | | +5.75% | 106B | | -3.11% | 63.67B | | +73.81% | 49.32B | | +15.46% | 38.56B | | +5.38% | 32.65B | | +11.13% | 20.08B | | +13.74% | 17.01B | | +20.05% | 15.41B | | +5.02% | 14.41B |
Other Commodity Chemicals
|